Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.75
Bid: 31.60
Ask: 31.85
Change: 0.35 (1.11%)
Spread: 0.25 (0.791%)
Open: 31.40
High: 32.20
Low: 31.40
Prev. Close: 31.40
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Rights Issue and placing of rump

22 Jul 2009 12:30

RNS Number : 0983W
Marston's PLC
22 July 2009
 



THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

22 July 2009

Marston's PLC ("Marston's" or "the Company")

Successful completion of Rights Issue and placing of rump

Marston's announced previously that it had received valid acceptances in respect of 273,269,134 New Shares, representing approximately 91.44% per cent of the total number of New Shares offered to Qualifying Shareholders, pursuant to the Rights Issue announced by the Company on 18 June 2009. 

Marston's confirms that, in accordance with the arrangements set out in Parts III and VII of the prospectus sent to Shareholders dated 18 June 2009 ("Prospectus"), RBS Hoare Govett and J.P. Morgan Cazenove, acting as Joint Bookrunners, have today procured subscribers for the 25,596,096 remaining New Shares not validly taken up, at a price of 85 pence per New Share. The net proceeds from the sale of such New Shares, after deduction of the Issue Price of 59.0 pence per New Share and the expenses of procuring subscribers (including any applicable brokerage and commissions and amounts in respect of VAT), will be paid to those Shareholders whose rights have lapsed in accordance with the terms of the Rights Issue, pro rata to the relevant provisional allotments not taken up, save that amounts of less than £5.00 per holding will not be so paid but will be aggregated and will accrue for the benefit of the Company. 

Unless otherwise defined in this announcement, capitalised terms shall have the meaning given to them in the Prospectus.

Contacts

For further information please contact:

Marston's PLC

+44 (0)1902 711 811

Ralph Findlay, Chief Executive

Andrew Andrea, Finance Director

Hudson Sandler:

+44(0)20 7796 4133

Andrew Hayes

Nick Lyon

James White

DISCLAIMER

This announcement does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security.

This announcement is an advertisement and does not constitute a prospectus or prospectus equivalent document. Nothing in this announcement should be interpreted as a term or condition of the Rights Issue. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Provisional Allotment Letter, Nil Paid Rights, Fully Paid Rights, and/or New Shares must be made only on the basis of the information contained in and incorporated by reference into the Prospectus. Copies of the Prospectus are available at the Company's registered office.

RBS Hoare Govett, J.P. Morgan Cazenove and Rothschild, which are regulated in the United Kingdom by the Financial Services Authority, are acting exclusively for the Company and for no-one else in relation to the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to their respective customers or for providing advice in relation to the Rights Issue or the contents of this announcement or any of the other matters referred to in this announcement.

The New Shares, the Nil Paid Rights, the Fully Paid Rights and the Provisional Allotment Letters have not been and will not be registered under the US Securities Act of 1933, as amended (the US Securities Act) and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, in the United States absent registration or pursuant to an exemption from, or in transactions not subject to, the registration requirements of the US Securities Act.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFXAAAXNEFE
Date   Source Headline
19th Jul 20188:47 amRNSDirector Declaration
10th Jul 20181:38 pmRNSBlock listing Interim Review
3rd Jul 20182:19 pmRNSDirector/PDMR Shareholding
2nd Jul 20182:48 pmRNSTotal Voting Rights
2nd Jul 20189:27 amRNSDirector/PDMR Shareholding
21st Jun 20189:57 amRNSHolding(s) in Company
19th Jun 20183:21 pmRNSDirector/PDMR Shareholding
19th Jun 201811:07 amRNSHolding(s) in Company
12th Jun 201810:13 amRNSDirector/PDMR Shareholding
6th Jun 20181:18 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSStatement re analyst site visit
23rd May 201812:09 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSInterim Results for 26 weeks ended 31 March 2018
11th May 201812:38 pmRNSAppointment of Interim Chairman
16th Apr 20189:51 amRNSHolding(s) in Company
3rd Apr 201811:01 amRNSTotal Voting Rights
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSAppointment of Chairman
21st Feb 20184:01 pmRNSHolding(s) in Company
6th Feb 20182:12 pmRNSDirector/PDMR Shareholding
24th Jan 20189:53 amRNSResult of AGM
23rd Jan 20187:00 amRNSTrading update for the 16 weeks to 20 January 2018
10th Jan 201810:07 amRNSBlock listing Interim Review
2nd Jan 20183:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20182:25 pmRNSTotal Voting Rights
20th Dec 20179:42 amRNSDirector Declaration
20th Dec 20177:00 amRNSWilliam Hill appoints Chairman Designate
18th Dec 20174:27 pmRNSAnnual Financial Report
12th Dec 20174:27 pmRNSDirector/PDMR Shareholding
12th Dec 20174:25 pmRNSDirector/PDMR Shareholding
5th Dec 20172:02 pmRNSDirector/PDMR Shareholding
1st Dec 201711:44 amRNSTotal Voting Rights
30th Nov 20177:00 amRNSPreliminary Results
27th Nov 20177:00 amRNSDirectorate
1st Nov 20171:17 pmRNSTotal Voting Rights
10th Oct 20177:00 amRNSYear-End Trading Update
2nd Oct 20172:48 pmRNSTotal Voting Rights
29th Sep 201710:27 amRNSDirector/PDMR Shareholding
8th Sep 20172:20 pmRNSDirector/PDMR Shareholding
5th Sep 201711:55 amRNSDirectorate Change
1st Sep 20171:47 pmRNSTotal Voting Rights
26th Jul 20177:00 amRNSTrading Update
11th Jul 20178:41 amRNSBlock listing Interim Review
5th Jul 20174:18 pmRNSDirector/PDMR Shareholding
4th Jul 20179:04 amRNSDirector/PDMR Shareholding
28th Jun 20174:03 pmRNSDirector/PDMR Shareholding
22nd Jun 20173:06 pmRNSDirector/PDMR Shareholding
20th Jun 20172:13 pmRNSDirector/PDMR Shareholding
20th Jun 20177:01 amRNSDirector Declaration
2nd Jun 20174:45 pmRNSCompletion of Acquisition of Charles Wells

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.